[1]
SilveiraA.A., SilvaF.R. de M., PereiraE.P., Severo SouzaF. da C., da CostaA.C., Souza Álvaro P.S., KhouriA.G., PinheiroY.V. and QuixabeiraV.B.L. 2019. Diagnostics and immunophenotyping monitoring of night paroxistic hemoglobinuria (pnh) and correlation with the efficacy of eculizumab treatment. Electronic Journal Collection Health. 37 (Dec. 2019), e1793. DOI:https://doi.org/10.25248/reas.e1793.2019.